Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (161-170 of 958) with videos related to

Pageof 96
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|February 8, 2023
The flare of care for rare: per aspera ad astra for rare lung diseases!Marlies Wijsenbeek, Marc Humbert, Thomas Wagner, et al.
La Revue Du Praticien|May 14, 2011
[Asthma: future challenges]Antoine Magnan, Manuel Tunon de Lara, Marc Humbert
Presse Medicale (Paris, France : 1983)|November 13, 2016
[New drugs for severe asthma]Caroline Sattler, Roxane Malrin, Gilles Garcia, et al.
Pulmonary Pharmacology & Therapeutics|April 9, 2017
Response to the article "Sorafenib as a potential strategy for refractory pulmonary arterial hypertension"Jason Weatherald, Marc Humbert, Christophe Guignabert, et al.
Archives of Cardiovascular Diseases|January 12, 2020
Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertensionFabrice Antigny, Olaf Mercier, Marc Humbert, et al.
Respiration; International Review of Thoracic Diseases|February 24, 2007
Genes and pulmonary arterial hypertensionBenjamin Sztrymf, Azzedine Yaïci, Barbara Girerd, et al.
Cardiovascular Research|December 10, 2019
Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectatorAlice Huertas, Ly Tu, Marc Humbert, et al.
The European Respiratory Journal|March 31, 2018
Risk assessment in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Marc Humbert, et al.
Current Rheumatology Reports|February 5, 2016
Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)Vincent Sobanski, David Launay, Eric Hachulla, et al.
The European Respiratory Journal|August 12, 2017
Immune checkpoint inhibitor-associated interstitial lung diseases: some progress but still many issuesDavid Montani, Andrei Seferian, Florence Parent, et al.
Pageof 96

Showing results (161-170 of 958) with videos related to

Sort By:
Pageof 96
European Respiratory Review : an Official Journal of the European Respiratory Society|February 8, 2023
The flare of care for rare: per aspera ad astra for rare lung diseases!Marlies Wijsenbeek, Marc Humbert, Thomas Wagner, et al.
La Revue Du Praticien|May 14, 2011
[Asthma: future challenges]Antoine Magnan, Manuel Tunon de Lara, Marc Humbert
Presse Medicale (Paris, France : 1983)|November 13, 2016
[New drugs for severe asthma]Caroline Sattler, Roxane Malrin, Gilles Garcia, et al.
Pulmonary Pharmacology & Therapeutics|April 9, 2017
Response to the article "Sorafenib as a potential strategy for refractory pulmonary arterial hypertension"Jason Weatherald, Marc Humbert, Christophe Guignabert, et al.
Archives of Cardiovascular Diseases|January 12, 2020
Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertensionFabrice Antigny, Olaf Mercier, Marc Humbert, et al.
Respiration; International Review of Thoracic Diseases|February 24, 2007
Genes and pulmonary arterial hypertensionBenjamin Sztrymf, Azzedine Yaïci, Barbara Girerd, et al.
Cardiovascular Research|December 10, 2019
Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectatorAlice Huertas, Ly Tu, Marc Humbert, et al.
The European Respiratory Journal|March 31, 2018
Risk assessment in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Marc Humbert, et al.
Current Rheumatology Reports|February 5, 2016
Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)Vincent Sobanski, David Launay, Eric Hachulla, et al.
The European Respiratory Journal|August 12, 2017
Immune checkpoint inhibitor-associated interstitial lung diseases: some progress but still many issuesDavid Montani, Andrei Seferian, Florence Parent, et al.
Pageof 96